Molecular probes for the human adenosine receptors. [PDF]
Purinergic Signal, 2021 Yang X +3 more
europepmc +1 more source
Az FSCPX az A1 adenozin receptor szelektív, irreverzibilis antagonistája. A munkacsoport korábbi vizsgálatai során az A1 adenozin receptor által mediált pitvari direkt negatív inotróp hatás receptor rezervje olyan nagynak bizonyult, ami megakadályozta a ...
Hornok, Bence
core
Pan RAS-binding compounds selected from a chemical library by inhibiting interaction between RAS and a reduced affinity intracellular antibody. [PDF]
Sci Rep, 2021 Tanaka T +4 more
europepmc +1 more source
The effect of a long-term treatment with cannabidiol-rich hemp extract oil on the adenosinergic system of the zucker diabetic fatty (ZDF) rat atrium. [PDF]
Front Pharmacol, 2022 Viczjan G +12 more
europepmc +1 more source
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update. [PDF]
Pharmacol Rev, 2022 IJzerman AP +4 more
europepmc +1 more source
Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors. [PDF]
Purinergic Signal, 2015 Massink A +7 more
europepmc +1 more source
Chemical Probes for the Adenosine Receptors. [PDF]
Pharmaceuticals (Basel), 2019 Federico S, Lassiani L, Spalluto G.
europepmc +1 more source
Scintillation proximity assay (SPA) as a new approach to determine a ligand's kinetic profile. A case in point for the adenosine A1 receptor. [PDF]
Purinergic Signal, 2016 Xia L +3 more
europepmc +1 more source
A1 Adenosine Receptor-Mediated Inhibition of Parasympathetic Neuromuscular Transmission in Human and Murine Urinary Bladder. [PDF]
J Pharmacol Exp Ther, 2016 Searl TJ +5 more
europepmc +1 more source
Hit-to-lead and lead optimization binding free energy calculations for G protein-coupled receptors. [PDF]
Interface Focus, 2020 Wan S +7 more
europepmc +1 more source